Literature DB >> 1513087

Ventilatory and metabolic changes during high efficiency hemodialysis.

T Symreng1, M J Flanigan, V S Lim.   

Abstract

Ventilatory and metabolic changes were measured in seven patients undergoing high efficiency hemodialysis using a cuprophane dialyzer and bicarbonate-containing dialysate. At an HCO3 concentration of 35 mEq/liter and a mean in vivo urea clearance of 3.6 ml/kg/min, hypoxemia was not detected during dialysis (PaO2 was 14.00 and 13.60 kPa before and during dialysis). The new findings, related to high efficiency bicarbonate dialysis, include a sustained rise in minute ventilation (VE, 6.1 to 6.8 liter/min, P less than 0.01), an increase in CO2 excretion (VCO2, 194 to 214 ml/min, P less than 0.05), and O2 consumption (VO2, 215 to 246 ml/min, P less than 0.05). The increment in VE and VCO2 was attributed to the high flux rate of bicarbonate while the rise in VO2 is likely the result of metabolic alkalosis. Arterial pH rose from 7.40 to 7.49 mm Hg and serum HCO3 increased from 23.8 to 29.2 mEq/liter, while pCO2 remained normal at 5.07 kPa throughout the study. The acid-base status of the blood changed from that of a metabolic acidosis to that of a respiratory acidosis across the dialyzer where the pH decreased from 7.47 to 7.41 and pCO2 rose from 5.31 to 7.72 kPa. These data indicate that a healthy ventilatory response is needed to excrete the excess CO2 generated during high efficiency bicarbonate hemodialysis. The significance and etiology of the elevated O2 consumption is undetermined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513087     DOI: 10.1038/ki.1992.162

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 2.  Bicarbonate Balance and Prescription in ESRD.

Authors:  Matthew K Abramowitz
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

Review 3.  Carbon dioxide: Global warning for nephrologists.

Authors:  Marco Marano; Anna D'Amato; Alessandra Cantone
Journal:  World J Nephrol       Date:  2016-09-06

4.  Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.

Authors:  Sarah Park; William Paredes; Matthew Custodio; Narender Goel; Deepak Sapkota; Anusha Bandla; Robert I Lynn; Suman M Reddy; Thomas H Hostetter; Matthew K Abramowitz
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-20

5.  Methylamine clearance by haemodialysis is low.

Authors:  Manish P Ponda; Zhe Quan; Michal L Melamed; Amanda Raff; Timothy W Meyer; Thomas H Hostetter
Journal:  Nephrol Dial Transplant       Date:  2009-12-17       Impact factor: 5.992

6.  The effect of bicarbonate administration via continuous venovenous hemofiltration on acid-base parameters in ventilated patients.

Authors:  Andrew S Allegretti; Jennifer E Flythe; Vinod Benda; Emily S Robinson; David M Charytan
Journal:  Biomed Res Int       Date:  2015-01-08       Impact factor: 3.411

Review 7.  Sodium bicarbonate therapy in patients with metabolic acidosis.

Authors:  María M Adeva-Andany; Carlos Fernández-Fernández; David Mouriño-Bayolo; Elvira Castro-Quintela; Alberto Domínguez-Montero
Journal:  ScientificWorldJournal       Date:  2014-10-21

8.  Acid-Base Status Disturbances in Patients on Chronic Hemodialysis at High Altitudes.

Authors:  Javier Enrique Cely; Oscar G Rocha; María J Vargas; Rafael M Sanabria; Leyder Corzo; Roberto E D'Achiardi; Eduardo A Zúñiga
Journal:  Int J Nephrol       Date:  2018-11-18

9.  Replenishing Alkali During Hemodialysis: Physiology-Based Approaches.

Authors:  F John Gennari; Marco Marano; Stefano Marano
Journal:  Kidney Med       Date:  2022-07-30

10.  Modeling acid-base balance during continuous kidney replacement therapy.

Authors:  John K Leypoldt; Mauro Pietribiasi; Jorge Echeverri; Kai Harenski
Journal:  J Clin Monit Comput       Date:  2021-01-03       Impact factor: 2.502

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.